Physician profile
Frederick Acquah
NPI 1366070187
$1,588.51
in general payments reported to CMS, 2019-2025
11 companies · $724 in 2025
The $724 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $165 · 2024: $700 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $526.96 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $353.66 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $197.43 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $152.45 | 2023-2025 | |
| Exact Sciences Corporation | $147.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $80.50 | 2025 | Shingrix |
| Dexcom, INC. | $66.35 | 2024-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $17.00 | 2023 | Ubrelvy |
| Smith+Nephew, INC. | $16.44 | 2025 | Collagenase Santyl |
| Medtronic, INC. | $15.71 | 2023 | Closurefast |
| Dynavax Technologies Corporation | $14.20 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Acquah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.